Prognostic Factors for Stage I Ovarian Carcinoma
- 1 January 2010
- journal article
- pathology of-the-upper-genital-tract
- Published by Wolters Kluwer Health in International Journal of Gynecological Pathology
- Vol. 29 (1) , 1-7
Abstract
Stage I ovarian carcinoma is relatively uncommon, and data on prognostic factors are conflicting. The clinical and pathologic features of 51 International Federation of Gynecology and Obstetrics stage I ovarian carcinomas were analyzed. There were 22 stage IA, 1 stage IB, and 28 stage IC cases. The mean follow-up was 6.1 years. The 5-year and 10-year disease-specific survival rates for the entire cohort were 92% and 78%, respectively. Among 51 patients, there were 6 tumor deaths, and 1 patient died of unrelated causes. All patients who died of disease were stage IC. Significant adverse prognostic factors were serous histology [relative risk (RR) 5.4, 95% confidence interval (CI) 1.3–22.0] and stage IC (RR 1.3, 95% CI 1.1–1.5). Among factors associated with stage IC, only positive washings or ascites affected survival (RR 9.25, 95% CI 1.9–44.4). The 5-year survival rates for stages IA and IC were 100% and 83%, respectively (PP<0.025, log rank test). Tumor rupture, surface involvement, histologic grade and clear cell histology were not of adverse prognostic significance. Serous histology and positive washings or ascites are adverse prognostic factors in stage I. The prognostic importance of tumor grade, rupture, surface involvement and clear cell histology remains unclear. Patients who are International Federation of Gynecology and Obstetrics stage I on the basis of comprehensive surgical staging have an excellent prognosis.Keywords
This publication has 30 references indexed in Scilit:
- Prognostic factors for high‐risk early‐stage epithelial ovarian cancerCancer, 2008
- Systematic review of adjuvant care for women with Stage I ovarian carcinomaCancer, 2004
- Clinicopathologic Analysis of Early-stage Sporadic Ovarian CarcinomaAmerican Journal of Surgical Pathology, 2004
- Analysis of failures in patients with stage I ovarian cancer: an Italian multicenter studyInternational Journal of Gynecological Cancer, 1997
- Natural history and prognosis of untreated stage I epithelial ovarian carcinoma.Journal of Clinical Oncology, 1996
- Adjuvant treatment for early epithelial ovarian cancer: Results of two randomised clinical trials comparing cisplatin to no further treatment or chromic phosphate (32P)Annals of Oncology, 1995
- Extraovarian Peritoneal Serous Papillary Carcinoma: A Case-Control Retrospective Comparison to Papillary Adenocarcinoma of the OvaryGynecologic Oncology, 1993
- Prognostic factors in well-differentiated early-stage epithelial ovarian cancerCancer, 1993
- Five-year survival for stage IC or stage I grade 3 epithelial ovarian cancer treated with cisplatin-based chemotherapyGynecologic Oncology, 1992
- Watch and wait after careful surgical treatment and staging in well-differentiated early ovarian cancerCancer, 1991